Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck

Head and Neck

Volumn 31, Issue 7, 2009, Pages 845-855

  Ronen, Ohad ^a   Malone, James P ^a   Kay, Paul ^a   Bivens, Christopher ^a   Hall, Kelly ^a   Paruchuri, Lakshmi P ^a   Mo, Yin Yuan ^a   Thomas Robbins, K ^a   Ran, Sophia ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial marker; Head and neck cancer; Novel SCCHN; Sumoylation; Ubc9

Indexed keywords

PROTEIN UBC9;

ADULT; ARTICLE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM BASAL CELL; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUCOSA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR GROWTH; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; UBIQUITIN-CONJUGATING ENZYMES;

EID: 67650478965     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21048     Document Type: Article

References (44)

1. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006;6:1111-1118. (Pubitemid 44203388)
2. St John MA, Abemayor E, Wong DT. Recent new approaches to the treatment of head and neck cancer. Anticancer Drugs 2006;17:365-375. (Pubitemid 44309978)
3. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005;86:347-363. (Pubitemid 41746374)
4. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;5:127-135. (Pubitemid 40220338)
5. Hasina R, Lingen MW. Head and neck cancer: the pursuit of molecular diagnostic markers. Semin Oncol 2004;31:718-725. (Pubitemid 39602677)
6. Muller S, Hoege C, Pyrowolakis G, Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2001;2:202-210.
7. Mo YY, Yu Y, Theodosiou E, Rachel Ee PL, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene 2005;24:2677-2683.
8. Johnson ES, Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem 1997;272:26799-26802. (Pubitemid 27452622)
9. Wang ZY, Qiu QQ, Seufert W, et al. Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9. J Biol Chem 1996;271:24811-24816. (Pubitemid 26333230)
10. Kovalenko OV, Plug AW, Haaf T, et al. Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes. Proc Natl Acad Sci U S A 1996;93:2958-2963. (Pubitemid 26114345)
11. Klein HL. A SUMOry of DNA replication: synthesis, damage, and repair. Cell 2006;127:455-457. (Pubitemid 44647434)
12. Seeler JS, Dejean A. Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 2003;4:690-699.
13. Shao R, Zhang FP, Tian F, et al. Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1alpha in adult mouse brain and heart in vivo. FEBS Lett 2004;569:293-300. (Pubitemid 38844635)
14. Comerford KM, Leonard MO, Karhausen J, Carey R, Colgan SP, Taylor CT. Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci U S A 2003;100:986-991. (Pubitemid 36183942)
15. Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem 2003;278:31043-31048. (Pubitemid 36994618)
16. Muller S, Ledl A, Schmidt D. SUMO: a regulator of gene expression and genome integrity. Oncogene 2004;23:1998-2008. (Pubitemid 38496729)
17. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998;2:233-239. (Pubitemid 128373648)
18. Epps JL, Tanda S. The Drosophila semushi mutation blocks nuclear import of bicoid during embryogenesis. Curr Biol 1998;8:1277-1280. (Pubitemid 28553820)
19. Ledl A, Schmidt D, Muller S. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 2005;24:3810-3818. (Pubitemid 40826879)
20. Johnson ES, Blobel G. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol 1999;147:981-994.
21. Doniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002;8:1127-1138. (Pubitemid 35177366)
22. Doniels-Silvers AL, Stoner GD, Lubet RA, You M. Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues. Neoplasia 2002;4:141-150. (Pubitemid 34218682)
23. Moschos SJ, Smith AP, Mandic M, et al. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene 2007;26:4216-4225. (Pubitemid 46975803)
24. Kabil O, Zhou Y, Banerjee R. Human cystathionine beta-synthase is a target for sumoylation. Biochemistry 2006;45:13528-13536. (Pubitemid 44753822)
25. Cheng TS, Chang LK, Howng SL, Lu PJ, Lee CI, Hong YR. SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization. Life Sci 2006;78:1114-1120. (Pubitemid 43143470)
26. Saitoh H, Pizzi MD, Wang J. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358. J Biol Chem 2002;277:4755-4763. (Pubitemid 34968507)
27. Panse VG, Kressler D, Pauli A, et al. Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway. Traffic 2006;7:1311-1321. (Pubitemid 44364170)
28. Yamaguchi YL, Tanaka SS, Yasuda K, et al. Stage-specific Importin13 activity influences meiosis of germ cells in the mouse. Dev Biol 2006;297:350-360. (Pubitemid 44353466)
29. Yamaguchi YL, Tanaka SS, Yasuda K, Matsui Y, Tam PP. Stage-specific Importin13 activity influences meiosis of germ cells in the mouse. Dev Biol 2006;297:350-360.
30. Tirard M, Almeida OF, Hutzler P, Melchior F, Michaelidis TM. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor. Mol Cell Endocrinol 2007;268:20-29. (Pubitemid 46428473)
31. Lin JY, Ohshima T, Shimotohno K. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. FEBS Lett 2004;573:15-18. (Pubitemid 39141028)
32. Pan X, Li H, Zhang P, et al. Ubc9 interacts with SOX4 and represses its transcriptional activity. Biochem Biophys Res Commun 2006;344:727-734.
33. Kurtzman AL, Schechter N. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci U S A 2001;98:5602-5607. (Pubitemid 32435688)
34. Bossis G, Melchior F. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol Cell 2006;21:349-357. (Pubitemid 43163530)
35. Carbia-Nagashima A, Gerez J, Perez-Castro C, et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 2007;131:309-323. (Pubitemid 47592916)
36. Wu F, Mo YY. Ubiquitin-like protein modifications in prostate and breast cancer. Front Biosci 2007;12:700-711. (Pubitemid 46852815)
37. Schmidt D, Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A 2002;99:2872-2877. (Pubitemid 34240553)
38. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999;18:6455-6461. (Pubitemid 29533249)
39. Ku TK, Crowe DL. Coactivator-mediated estrogen response in human squamous cell carcinoma lines. J Endocrinol 2007;193:147-155. (Pubitemid 46638541)
40. Ishida H, Wada K, Masuda T, et al. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci 2007;98:636-643. (Pubitemid 46563438)
41. Golebiowski F, Szulc A, Sakowicz M, Szutowicz A, Pawelczyk T. Expression level of Ubc9 protein in rat tissues. Acta Biochim Pol 2003;50:1065-1073.
42. Mo YY, Yu Y, Ee PL, Beck WT. Overexpression of a dominant- negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res 2004;64:2793-2798. (Pubitemid 38500617)
43. Mo YY, Moschos SJ. Targeting Ubc9 for cancer therapy. Expert Opin Ther Targets 2005;9:1203-1216.
44. Matunis MJ, Pickart CM. Beginning at the end with SUMO. Nat Struct Mol Biol 2005;12:565-566.